Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Lancet Neurol. 2016 Dec;15(13):1336–1345. doi: 10.1016/S1474-4422(16)30295-2

Table 1. Clinical and demographic characteristics.

Group Number of seizures Number of patients Number of females (%) Age (years, mean ± SD) Duration of epilepsy (years, mean ± SD) Number of patients off medication pre-study (%)
Patients without seizures 0 54 27 (50%) 10·6 ± 3·7 4·0 ± 3·7 6 (11%)
Patients with seizures 1032 39 23 (59%) 9·9 ± 3·1 3·0 ± 2·5 14 (36%)
Comparison* P= 1·000 P=0·329 P= 0·128 P=0 005
Spared seizures total 139 21 11 (52%) 10·6 ± 3·2 2·9 ± 0·9 6 (29%)
Impaired seizures total 160 27 17 (63%) 100 ± 31 3·2 ± 2·6 11 (41%)
Comparison* P=0·560 P=0·541 P=0·691 P=0·544
Spared seizures fMRI 93 17 8 (47%) 10·7 ± 3·3 3·3 ± 21 5 (29%)
Impaired seizures fMRI 112 22 16 (73%) 10·2 ± 3·3 3·8 ± 2·3 8 (36%)
Comparison* P=0 184 P=0·631 P=0·554 P=0·740
Spared seizures HD-EEG 30 5 2 (40%) 13·5 ± 3·6 3·3 ± 2·9 4 (80%)
Impaired seizures HD-EEG 26 8 5 (63%) 110 ± 4·5 2·8 ± 2·8 5 (63%)
Comparison* P=0·592 P=0·303 P=0·752 P= 1·000

Spared and impaired seizures total groups include all seizures used for analyses in Figures 2, 4, 5 and 6. Spared and impaired seizures fMRI or HD-EEG groups include all seizures used for Figures 4, 5 and 6.

*

Two-tailed t-test was used for age and duration of epilepsy; Fisher's exact test was used for % female and % off medication pre-study.

See also Table S1 for additional characteristics of individual patients with seizures.